PharmaNet Development Group is a leading service provider for both branded and generic drugs. With more than 30 percent of their clinical research experience in biotechnology products, PharmaNet professionals have extensive experience in biotechnology product development and can provide advice on topics covering the entire spectrum of development, including both early stage clinical trials and multi-site global trials in almost all therapeutic areas.

Our consulting professionals have significant experience with international regulatory guidelines, including EMEA Guidance, Health Canada Draft Guidance, and FDA legislative debates. These professionals include former senior-level FDA officials who were past members of the FDA Follow-on Biologics Committee as well as subcommittees on CMC and immunogenicity issues.